Navigation Links
Generex Presents Abstract at EASD Annual Meeting
Date:9/22/2010

WORCESTER, Mass., Sept. 22 /PRNewswire/ -- Generex Biotechnology Corporation (Nasdaq: GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it is presenting study results at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD, www.easd.org) being held in Stockholm, Sweden, 20 - 24 September, 2010 (www.easd2010.com).

An abstract entitled No Generation of Insulin Antibodies in Subjects with Impaired Glucose Tolerance Treated With Buccal Spray Insulin is a poster presentation at the symposium.  The abstract is authored by physicians from the Endocrinology and Diabetes Department, University "Campus Bio-Medico" and the Diabetes Department, Hospital "St. Pertini", both of Rome, Italy.

The abstract presents data from a study demonstrating that treatment with the Company's propriety buccal insulin spray product, Generex Oral-lyn™, is a valuable tool for managing hyperglycaemia in subjects with impaired glucose tolerance.  "There is little doubt that the imperative for treating impaired glucose tolerance is mounting across the diabetes universe. This study adds another measure of safety to the use of buccal delivery of insulin to achieve this goal" commented Dr. Gerald Bernstein, Generex's Vice-President for Medical Affairs.

The EASD Annual Meeting, which brings together more than 14,000 delegates in the healthcare industry, is a premier platform for professional exchange in the field of diabetes. The EASD brings together scientists, physicians, laboratory workers, nurses, and students from all over the world who are interested in diabetes and related subjects.

About Generex Biotechnology Corporation

Gen
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Announces Sales Agreement with Elias Shaker & Company
2. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
5. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
6. Curemark Presents at the Rodman & Renshaw Annual Global Investment Conference
7. Sono-Tek Presents at the 15th International Coating Science and Technology Symposium (ISCST, St. Paul, MN)
8. CVS Caremark Presents Ongoing Behavioral Change Research Partnership Research to the Pittsburgh Business Group on Health
9. ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmins Potential to Transform the Treatment of Retinal Disorders
10. Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
11. U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... DIEGO , Aug. 26, 2014  Sorrento ... a late-stage clinical oncology company developing new treatments ... that it has received funding to advance an ... potential treatment of IPF, which affects more than ... the lungs increases and patients gradually lose the ...
(Date:8/26/2014)... , Aug. 26, 2014 MNX ... that it has renewed a multi-year contract providing ... the third largest spinal device company in the ... medical device industry is well suited to MNX,s ... that every shipment involves a surgeon, surgical team ...
(Date:8/26/2014)... DIEGO , Aug. 26, 2014 Profil ... research organization (CRO) focused on diabetes and obesity, announced ... completion of more than 200 phase I – IIa ... the treatment of type 1 and type 2 diabetes. ... of research is what it represents for the public ...
Breaking Medicine Technology:Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3MNX Global Logistics renews multi-year contract with NuVasive, Inc. 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 3
... Improvement With Every-Four-Week Subcutaneous SIMPONI Despite Previous Medication ... June 9 A new analysis demonstrated that ... severely active rheumatoid arthritis (RA) who had prior ... received subcutaneous injections of SIMPONI(TM) (golimumab) once every ...
... in June Issue of Circulation , , SILVER ... Corporation (Nasdaq: UTHR ) and Eli Lilly ... the results of a pivotal 16-week study showing that ... improved exercise capacity and improved time to clinical worsening ...
Cached Medicine Technology:New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 2New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 3New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 4New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 5New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 6New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 7New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 8New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 9New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients 10Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 2Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 3Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 4Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 5Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 6
(Date:8/27/2014)... 2014 AvePoint, the ... software solutions for next-generation social collaboration platforms, announced ... 500|5000, an exclusive ranking of the nation’s fastest-growing ... joins brands such as Alex and Ani, Gazelle, ... , This underscores continued growth and expansion for ...
(Date:8/27/2014)... 27, 2014 Discover Leadership Training is ... corporate transformation through their comprehensive leadership programs. As the ... unparalleled experience in the realm of outcome-focused and benefit-driven ... in a new webinar series titled, “A Women’s Guide ... first of this two part webinar is titled, “My ...
(Date:8/27/2014)... is one of the most loved online bamboo product suppliers; ... now. Recently, it has announced its new selection of ... strives to offer one-stop shopping solutions for people who want ... it is providing big discounts for all the brand new ... a discounted price (up to 30% off) before the deadline ...
(Date:8/27/2014)... Overcoming a turbulent past which branded KC Armstrong as ... Radio Network, WRNW1, has recently signed a multi-million dollar contract ... the WRNW1 family. KC states, “it is such a great ... After KC Armstrong publicly announced his appreciation to Howard Stern, ... “Howard 100 News,” have decided to pay it forward. , ...
(Date:8/27/2014)... 27, 2014 AttorneyOne.com, a recognized authority ... latest information from the FDA on Organic Raw ... 1, that Organic Raw Carob Powder sold from March ... due to possible contamination with Salmonella. , Salmonella ... immune systems. In healthy people it can cause abdominal ...
Breaking Medicine News(10 mins):Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Barb Moses, Vice President of Discover Leadership Training, Announces New Webinar Titled, “A Women’s Guide to Making Her Life Story a Bestseller” 2Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
... Reporter , MONDAY, Feb. 7 (HealthDay News) -- Babies ... were 4 months old were more likely to be obese ... solid foods didn,t increase the odds of becoming obese in ... breast-fed -- or who stopped breast-feeding before the age of ...
... and Emilio Botn, president of Banco Santander have ... in Boadilla del Monte) the new facilities for ... (Progression of Early Subclinical Atherosclerosis) CNIC-Santander study. The ... Research (CNIC) and Grupo Santander is aimed at ...
... The majority of fatal cases of malaria are caused ... at risk are young children and women who are pregnant. ... National Institutes of Health, Rockville, has now developed an approach ... way that they are able to identify parasite genes associated ...
... cause of many diseases. Gene therapy direct replacement of ... of correcting such defects. Now a research team based at ... by Privatdozent Dr. Carsten Rudolph, has taken a new approach ... time that chemical modification of mRNAs (the metabolically active molecules ...
... A digital signal processing technique long used by statisticians ... roots of memory and learning, Alzheimer,s and Parkinson,s diseases ... University of Texas Health Science Center at Houston (UTHealth) ... that single molecule fluorescence resonance energy transfer (FRET) ...
... levels and menstrual bleeding pattern in women with polycystic ... Gothenburg, Sweden., PCOS is a common disorder that affects ... Women with PCOS frequently have irregular ovulation and menstruation, ... This causes the ovaries to produce more testosterone which, ...
Cached Medicine News:Health News:Giving Baby Solid Foods Too Early Linked to Obesity Later 2Health News:Giving Baby Solid Foods Too Early Linked to Obesity Later 3Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 2Health News:CNIC and Grupo Santander present a new venue for imaging tests included in PESA study 3Health News:JCI online early table of contents: Feb. 7, 2011 2Health News:JCI online early table of contents: Feb. 7, 2011 3Health News:JCI online early table of contents: Feb. 7, 2011 4Health News:JCI online early table of contents: Feb. 7, 2011 5Health News:JCI online early table of contents: Feb. 7, 2011 6Health News:JCI online early table of contents: Feb. 7, 2011 7Health News:Save messengers -- modified mRNAs open up new therapeutic possibilities 2Health News:Researchers get a grip on nervous system's receptors 2Health News:Researchers get a grip on nervous system's receptors 3
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: